Table 1.
Characteristics of elderly patients with locally advanced rectal cancer.
| Characteristics | No. (%) | |
|---|---|---|
| Total | 85 | |
| Age | Median: 80 (range: 75-90 years) | |
| Gender | ||
| Male | 61 (71.8%) | |
| Female | 24 (28.2%) | |
| Tumor differentiation (pretreatment) | ||
| Poorly | 9 (10.6%) | |
| Moderately | 43 (50.6%) | |
| Well | 9 (10.6%) | |
| Undefined | 24 (28.2%) | |
| Tumor location | ||
| Low (<5cm) | 42 (49.4%) | |
| Middle (5-10cm) | 43 (50.6%) | |
| T stage (pretreatment) | ||
| T1 | 2 (2.4%) | |
| T2 | 4 (4.7%) | |
| T3 | 73 (85.8%) | |
| T4 | 6 (7.1%) | |
| N stage (pretreatment) | ||
| N0 | 24 (28.2%) | |
| N1 | 39 (45.9%) | |
| N2 | 22 (25.9%) | |
| Concurrent chemotherapy | ||
| None | 12 (14.1%) | |
| Capecitabine | 54 (63.5%) | |
| Xelox | 19 (22.4%) | |
| Radiotherapy | ||
| 3D-CRT | 7 (8.2%) | |
| VMAT | 65 (76.5%) | |
| HT | 13 (15.3%) | |
| Surgery | ||
| None | 29 (34.1%) | |
| TME | 48 (56.5%) | |
| Dixon | 35 (72.9%) | |
| Miles | 10 (20.8%) | |
| Hartmann | 2 (4.2%) | |
| Parks | 1 (2.1%) | |
| TEM | 8 (9.4%) | |
Abbreviations 3D-CRT: 3-dimensional conformal radiotherapy, VMAT: volumetric modulated arc radiotherapy, HT: helical tomotherapy, TME: total mesorecal excision, TEM: transanal endoscopic microsurgery, Xelox: capecitabine plus oxaliplatin.